EGFR and breast carcinoma: Based on previously published results [37,67] and the confirmed interplay between EGFR and ERs, our goal for this study was to evaluate the impact that different matrix substrates have on morphological aspects of breast cancer cells, following EGFR inhibition in the presence and absence of 17β-estradiol.